US PTAB Patent Cases
8,722 decisions indexed
Page 7 of 291 · 8,722 total
Google LLC v.Secure Communication Technologies, LLC
Google’s IPR against patent 8116749 resulted in a mixed decision: five claims were held unpatentable over Perttila and Insolia, while four claims remained patentable because the obviousness challenge failed.
Google LLC v.Secure Communication Technologies, LLC
Google successfully challenged Target’s ’359 patent covering proximity‑based wireless transactions. The PTAB found all nine challenged claims unpatentable, citing anticipation and obviousness over Perttila and the Perttila‑Swartz combination.
Google LLC v.Secure Communication Technologies, LLC
Google successfully challenged Secure Communication Technologies’ patent covering proximity‑based wireless information exchange. The PTAB found all fifteen challenged claims unpatentable under §§102 and 103, based on the Eagle prior art.
Google LLC v.Secure Communication Technologies, LLC
Google petitions the PTAB to invalidate a wireless‑communication patent, arguing that its claims are anticipated or obvious over earlier Bluetooth‑based systems such as Eagle and Mgrdechian.
Citadel Securities LLC v.HFT Solutions, LLC
Citadel Securities petitions the PTAB to invalidate six claims of HFT Solutions’ ’286 patent, alleging that the FPGA‑PLL synchronization method is fully disclosed in Altera’s white paper, the Stratix Handbook, the Si5345 manual, and a 2012 Lockwood paper.
Amazon.com, Inc. et al. v.InterDigital VC Holdings, Inc. et al.
Amazon has filed an IPR petition challenging InterDigital’s ’876 patent covering large‑block intra‑prediction in video codecs. The petition asserts obviousness over Xiong, VCEG‑AJ21, and H.264, seeking cancellation of claims 1‑18.
Google LLC v.Secure Communication Technologies, LLC
Google LLC petitions the PTAB to institute an IPR and cancel all 26 claims of Secure Communication Technologies' U.S. Patent 8,116,749, arguing that prior art (Bucuk, Nordman, Kallio, Perttila) anticipates or makes the claims obvious.
Amazon.com, Inc. et al. v.InterDigital Madison Patent Holdings, SAS et al.
Amazon has filed an IPR petition seeking cancellation of four claims of InterDigital’s HEVC‑related ’877 patent, asserting obviousness over multiple prior‑art references under 35 U.S.C. §103.
Google LLC v.Gamba Group Holdings LLC
Google LLC filed an IPR petition against Gamba Group Holdings LLC’s 9,772,193 patent covering Bluetooth and GPS‑based parking‑location methods. The petition asserts anticipation by Baese and Phillips and obviousness with Phillips and Soliman, seeking cancellation of claims 12, 13, and 15‑18. The Board has not yet ruled on institution.
Microsoft Corporation v.Qomplx LLC
Microsoft has petitioned the PTAB to invalidate Qomplx’s multi-factor authentication patent, asserting that the claims are obvious over the Kirti patent and the Coffin textbook. The petition seeks institution of IPR on claims 1‑21, 23‑28, and 30.
Guardant Health, Inc. v.Tempus AI, Inc.
Guardant Health filed an IPR petition seeking cancellation of all 18 claims of Tempus AI’s 10,991,097 patent, asserting anticipation by Chukka and obviousness over Chukka combined with Jones, Sebastiao, and Gallas. The petition argues the prior art was not considered during prosecution.
Microsoft Corporation v.Qomplx LLC
Microsoft has filed a petition for inter partes review of Qomplx’s U.S. Patent 12,218,934 covering contextual, risk‑based multi‑factor authentication. The petition asserts that claims 1‑30 are obvious over prior art including the Kirti patent, the Coffin textbook, and Vemulapalli’s virtual‑machine teachings. No objective evidence of non‑obviousness is presented.
Microsoft Corporation v.Sandpiper CDN, LLC
Microsoft has filed an IPR petition challenging all 50 claims of Sandpiper CDN’s ’053 patent, asserting obviousness over a suite of CDN‑related prior art. The petition seeks institution of the proceeding and cancellation of the claims.
Microsoft Corporation v.Sandpiper CDN, LLC
Microsoft has filed an IPR petition challenging U.S. Patent 10,701,173, which covers CDN cache‑policy methods. The petition alleges obviousness over multiple prior‑art references and seeks cancellation of all fourteen claims.
Paragon 28, Inc. v.TREACE MEDICAL CONCEPTS, INC.
Treace Medical announced a confidential settlement with Fusion Orthopedics, ending a lawsuit over bunion‑correction patents. The settlement resolves claims of infringement, trademark, and copyright disputes.
Paragon 28, Inc. v.TREACE MEDICAL CONCEPTS, INC.
Paragon 28 seeks to invalidate Treace Medical Concepts' 12,268,428 bunion‑correction patent, alleging that all 30 claims are anticipated or obvious over well‑known surgical textbooks and prior‑art patents. The petition lists ten grounds covering §§102 and 103 and requests the Board to institute review and cancel the claims.
Pfizer Inc. v.Pogona, LLC
Pfizer has filed an IPR petition seeking cancellation of all 19 claims of U.S. Patent 11,058,757 covering pneumococcal conjugate vaccines, arguing that the claims are anticipated or obvious over prior art such as Alexander and Gu, plus extensive epidemiology literature.
Paragon 28, Inc. v.TREACE MEDICAL CONCEPTS, INC.
Treace Medical announced a confidential settlement with Fusion Orthopedics, ending a patent infringement lawsuit tied to its Lapiplasty bunion‑correction system. The settlement concludes the related PGR proceeding (PGR2026‑00017).
Paragon 28, Inc. v.TREACE MEDICAL CONCEPTS, INC.
Paragon 28 seeks to invalidate all 30 claims of Treace's bunion‑correction patent, alleging lack of written description, enablement, and obviousness over prior‑art guides and textbooks.
Nyxoah, Inc. et al. v.Inspire Medical Systems, Inc.
Nyxoah has filed an IPR petition challenging Inspire Medical Systems' patent on hypoglossal nerve stimulation for sleep‑disordered breathing, asserting obviousness over multiple prior‑art references.
Nyxoah, Inc. et al. v.Inspire Medical Systems, Inc.
Nyxoah has filed an IPR petition seeking to invalidate Inspire Medical Systems' patent on hypoglossal nerve stimulation for sleep apnea. The petition asserts obviousness over prior‑art neurostimulator references (Durand/Hoegh and Headley/Tran). The Board is asked to institute review and cancel the claims.
Nyxoah, Inc. et al. v.Inspire Medical Systems, Inc.
Nyxoah has filed an IPR petition challenging Inspire Medical's U.S. Pat. 10,898,709, asserting that all 15 claims are obvious over earlier neurostimulation disclosures such as Durand, Hoegh, Headley and Tran. The petition seeks institution of review and cancellation of the claims.
Ebury Partners UK Ltd. v.--
Ebury Partners UK Ltd. and Intercurrency Software LLC entered into a settlement that grants Ebury a royalty‑free license to several patents covering cross‑border payments, includes covenants not to sue, and mandates dismissal of the pending IPR and related lawsuit.
Microsoft Corporation v.Sandpiper CDN, LLC
Microsoft seeks Director Review of a PTAB institution decision that ordered review of an expired content‑delivery patent owned by Sandpiper CDN. The petition argues the Board misapplied settled‑expectations doctrine and misread the district‑court record, making the decision an outlier.
Ebury Partners UK Ltd. v.--
Ebury Partners UK Ltd. moved to withdraw its IPR petition after settling with Intercurrency Software LLC. The Board was asked to terminate the proceeding, which was unopposed and at an early stage.
Microsoft Corporation v.Sandpiper CDN, LLC
The PTAB denied Google’s petitions for Director Review of institution decisions in four IPRs against Sandpiper CDN, keeping the institutions intact.
Microsoft Corporation v.Sandpiper CDN, LLC
Microsoft has filed an IPR petition challenging Sandpiper CDN’s 9,762,692 patent covering CDN popularity‑based routing and content partitioning, asserting obviousness over Seed and Swildens references.
Ebury Partners UK Ltd. v.--
Ebury Partners UK Ltd. petitions the PTAB to invalidate 16 claims of Intercurrency Software’s ‘701 patent, asserting that the claims are obvious over a combination of prior‑art trading systems (Calo, Rude, Sellberg, Szoc, Davidowitz).
Imperative Care, Inc. v.Inari Medical, Inc. et al.
The PTAB instituted an IPR on Inari Medical’s 11,697,012 patent covering hemostasis valves for aspiration catheters after finding a reasonable likelihood that Imperative Care will prevail on at least one of the nine challenged claims.
Imperative Care, Inc. v.Inari Medical, Inc. et al.
Imperative Care challenged Inari Medical’s 11,844,921 B2 hemostasis valve patent. The PTAB found a reasonable likelihood of unpatentability and instituted inter partes review on all 18 challenged claims.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.